Partnership to Accelerate Clinical Trials (PACT)
At a Glance
- Status: Active Consortium
- Year Launched: 2014
- Initiating Organization: Bay Area BioEconomy Initiative
- Initiator Type: Academia
- No disease focus
- Location: North America
The Partnership to Accelerate Clinical Trials (PACT) consists of 11 California health systems and medical research institutions, including five University of California (UC) campuses, Stanford University, Children's Hospital Oakland, Dignity Health, and Sutter Health.
PACT originated through Clay Johnston, UC San Francisco (SF) associate vice chancellor of research, as a Bay Area-centric effort to help drug developers launch and manage multiple clinical trial sites. PACT will manage a centralized institutional review board (IRB), assuring that each trial site's standards are met.
PACT aims to halve the typical multi-month startup process of initiating clinical trials—time that contributes substantially to cost, ultimately impeding progress in developing new treatment options for patients.
Once implemented in California, Bay Area BioEconomy Initiative and PACT plan to grow the network across the U.S., with the goal of creating a national model to accelerate and increase the quality of clinical trials.
January 2014: PACT announced
Support for the development of PACT is provided by UCSF’s Clinical and Translational Science Institute, which is funded by the National Center for Advancing Translational Sciences at the National Institutes of Health (Grant Number UL1 TR000004).
Sponsors & Partners
Children’s Hospital Oakland
University of California, Davis
University of California, San Francisco